Voyager Therapeutics, Inc. (VYGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Voyager Therapeutics, Inc. (VYGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Voyager Therapeutics, Inc. (VYGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Voyager Therapeutics, Inc. (VYGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
26 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Voyager Therapeutics, Inc. (Voyager) is a gene therapy company that develops treatments for fatal and debilitating diseases of the central nervous system. The company provides treatment for adeno-associated virus gene therapy field by selecting, designing and manufacturing vectors. Its product includes VY-AADC01, which is under Phase 1b study, is used for treating Parkinsons disease. Voyagers pipeline also comprise preclinical programs for amyotrophic lateral sclerosis, Friedreichs ataxia, Huntington's disease and spinal muscular atrophy.

Voyager Therapeutics, Inc. (VYGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, de

  
Source:
Document ID
GDPH509617D
Country
Industry
Ticker
VYGR=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Voyager Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Voyager Therapeutics, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Voyager Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Voyager Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Voyager Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Voyager Therapeutics, Inc., Pharmaceuticals &Healthcare, Deal Details1013
  Venture Financing101
    Voyager Therapeutics Raises USD60 Million in Series B Financing101
    Voyager Therapeutics Raises US$45 Million In Series A Financing111
  Partnerships121
    Voyager Therapeutics Enters into Research Agreement with CHDI Foundation121
    Voyager Therapeutics Enters into Development Agreement with Genzyme131
    Voyager Therapeutics Enters into Agreement with MassBiologics141
  Licensing Agreements151
    Voyager Therapeutics Enters into Licensing Agreement with California Institute of Technology151
    Voyager Therapeutics Enters into Licensing Agreement with ReGenX Biosciences162
    Voyager Therapeutics Enters into Licensing Agreement with University of Massachusetts182
  Equity Offering201
    Voyager Therapeutics Raises USD80.5 Million in IPO202
    Voyager Therapeutics Raises USD30 million in Private Placement of Series B Preferred Stock221
Voyager Therapeutics, Inc. - Key Competitors231
Key Employees241
Locations And Subsidiaries251
  Head Office251
Appendix261
  Methodology261
  About GlobalData261
  Contact Us261
  Disclaimer261

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Voyager Therapeutics, Inc. (VYGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Voyager-Therapeutics-Inc-VYGR-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25426>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Voyager Therapeutics, Inc. (VYGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Voyager-Therapeutics-Inc-VYGR-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25426>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research